Type of security: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
The data is delayed by 15 minutes.
Description: Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. It offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products used to treat patients with atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. The company also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters to treat patients with peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat patients with non-vascular disease. In addition, it offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and tr
|Shares Outstanding||EPS||0.73||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-5.61%||Sales Growth - Q/Q||-6.31%||P/E||38.01|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-1.54%||ROE||-3.89%||ROI||-1.94%|
|Current Ratio||1.29||Quick Ratio||0.91||Long Term Debt/Equity||5.3||Debt Ratio||0.38|
|Gross Margin||70.26%||Operating Margin||-6.43%||Net Profit Margin||-3.43%||Dividend Payout Ratio|
|Cash From Financing Activities||-94 M||Cash From Investing Activities||-51 M||Cash From Operating Activities||-197 M||Gross Profit||1.3 B|
|Net Profit||102 M||Operating Profit||219 M||Total Assets||17.12 B||Total Current Assets||3.77 B|
|Total Current Liabilities||1.94 B||Total Debt||5.11 B||Total Liabilities||10.54 B||Total Revenue||1.84 B|
|High 52 week||43.2||Low 52 week||31.73||Last close||43.2||Last change||1.03%|
|RSI||55.54||Average true range||1.01||Beta||0.89||Volume||4.25 M|
|Simple moving average 20 days||1.82%||Simple moving average 50 days||3.23%||Simple moving average 200 days||12.62%|
|Performance Week||1.05%||Performance Month||0%||Performance Quart||18.1%||Performance Half||10.23%|
|Performance Year||25.98%||Performance Year-to-date||22.24%||Volatility daily||1.34%||Volatility weekly||2.99%|
|Volatility monthly||6.12%||Volatility yearly||21.2%||Relative Volume||246.39%||Average Volume||6.81 M|
|New High||New Low|
2019-09-19 09:35:00 | 10 Stable Growth Stocks That Are Still Worth the Price, According to an Analyst
2019-09-13 09:40:01 | BAX or BSX: Which Is the Better Value Stock Right Now?
2019-09-13 09:13:01 | IoMT Becomes the Buzzword in New Age MedTech Investing
2019-09-10 11:07:35 | Morgan Stanley: Buy These 3 Stocks on Recent Weakness
2019-09-10 07:13:25 | 3 Big Stock Charts for Tuesday: Boston Scientific, GM and United Airlines
2019-09-02 08:26:15 | Does Boston Scientific Corporation's NYSE:BSX CEO Pay Reflect Performance?
2019-08-26 10:47:02 | Boston Scientific Closes BTG Buyout, PI Arm to Get a Boost
2019-08-23 09:31:01 | Boston Scientific BSX Up 1.6% Since Last Earnings Report: Can It Continue?
2019-08-20 09:30:01 | BAX vs. BSX: Which Stock Is the Better Value Option?
2019-08-20 09:03:01 | Boston Scientific's BSX Vercise Gevia DBS Gets FDA Nod
2019-08-20 09:01:01 | Here's Why You Should Hold Varian Medical VAR Stock Now
2019-08-19 06:00:00 | Boston Scientific Closes Acquisition of BTG plc.
2019-08-15 10:15:02 | FDA Resets PAD Guidelines: The Road Ahead for Device Makers
2019-08-15 09:44:01 | Cardiovascular Systems Set to Present LIBERTY 360 Outcome
2019-08-15 07:58:16 | Don't Sell Boston Scientific Corporation NYSE:BSX Before You Read This
2019-08-15 05:55:48 | Bain executive joins biotech startup Cerevel's C-suite
2019-08-13 10:18:02 | Boston Scientific Rides on New Products Amid Dull Pacer Sales
2019-08-12 13:14:38 | Top Analyst Reports: Amgen, Uber, Mondelez & More
2019-08-02 13:56:40 | David Carlson Goes 2 for 2 in 2nd Quarter
2019-07-30 10:22:02 | 4 Medical Product Stocks Set to Beat This Earnings Season
2019-07-29 08:00:00 | Mayo Clinic, Boston Scientific teaming up on med-tech accelerator
2019-07-28 09:02:30 | What We Think Of Boston Scientific Corporation’s NYSE:BSX Investment Potential
2019-07-27 12:17:00 | 10 Biggest Medical Device Stocks
2019-07-25 09:30:00 | Boston Scientific to Participate in 39th Annual Canaccord Genuity Growth Conference
2019-07-24 20:24:19 | Boston Scientific BSX Q2 2019 Earnings Call Transcript
2019-07-24 18:06:55 | Edited Transcript of BSX earnings conference call or presentation 24-Jul-19 12:00pm GMT
2019-07-24 16:24:27 | Two Medtech Giants Top Earnings Views And Narrowly Hold Onto Buy Points
2019-07-24 16:00:00 | What You'll Want to Know About Boston Scientific's Q2 Earnings
2019-07-24 10:56:02 | Boston Scientific BSX Q2 Earnings Top on Growth in All Lines
2019-07-24 07:45:11 | Boston Scientific BSX Surpasses Q2 Earnings Estimates
2019-07-24 07:20:00 | Boston Scientific tops second-quarter profit expectations but misses on revenue
2019-07-24 07:05:51 | UPDATE 2-Boston Scientific's narrow profit beat fails to excite investors
2019-07-24 06:40:53 | Boston Scientific profit falls 72% on acquisition charges
2019-07-24 06:30:00 | Boston Scientific Announces Results For Second Quarter 2019
2019-07-23 17:36:36 | CEO calls it an 'important day for women's health.' Wall Street appears unimpressed
2019-07-23 13:04:00 | [video]Boston Scientific Expected to Earn 38 Cents a Share
2019-07-22 10:15:02 | What's in Store for Boston Scientific's BSX Q2 Earnings?
2019-07-18 10:42:02 | Will USTR's 25% Tariff Exemption Spell Relief for MedTech?
2019-07-17 16:19:15 | These 4 Medical Stocks Could Benefit From J&J Earnings — Here's Why
2019-07-17 10:32:02 | Earnings Preview: Boston Scientific BSX Q2 Earnings Expected to Decline
2019-07-17 08:01:12 | US-India Trade Tensions Rise: 3 Stocks in the Line of Fire
2019-07-12 08:13:12 | Tap AI-Powered Medical Device Stocks as FDA Bolsters SaMD
2019-07-10 15:13:07 | Top Stock Reports for Bank of America, Eli Lilly & Boston Scientific
2019-07-10 11:11:03 | Boston Scientific's Global Growth Robust Amid Currency Woe
2019-07-09 08:00:59 | See what the IHS Markit Score report has to say about Boston Scientific Corp.